Related Experiment Video
Updated: Aug 6, 2026
12:27
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Cellular signalling by sphingosine kinase and sphingosine 1-phosphate
Tamara M Leclercq1, Stuart M Pitson
1Hanson Institute, Division of Human Immunology, Institute of Medical and Veterinary Science, Adelaide, Australia.
IUBMB Life
|August 19, 2006
Summary
Sphingosine kinases (SKs) and their product sphingosine 1-phosphate (S1P) regulate key cell functions. Targeting SK activation and location offers promising therapeutic strategies for cancer and inflammation.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Pharmacology
Background:
- Sphingosine kinases (SKs) produce sphingosine 1-phosphate (S1P), a bioactive lipid mediator.
- S1P signaling is crucial for cellular processes like proliferation, apoptosis, and angiogenesis.
- Recent advances have illuminated SKs' mechanisms, regulation, and biological roles.
Purpose of the Study:
- To review the current understanding of sphingosine kinase and sphingosine 1-phosphate signaling.
- To discuss the therapeutic potential of targeting sphingosine kinases.
- To explore novel therapeutic strategies focusing on enzyme activation and localization.
Main Methods:
- Literature review of recent research on sphingosine kinases and sphingosine 1-phosphate.
- Analysis of cellular processes regulated by SK/S1P.
- Evaluation of sphingosine kinase as a therapeutic target.
Main Results:
- Sphingosine kinases are involved in cell proliferation, apoptosis, calcium homeostasis, angiogenesis, and vascular maturation.
- SKs and S1P play significant roles in diverse cellular signaling pathways.
- Recent findings highlight SKs as potential therapeutic targets for various diseases.
Conclusions:
- Targeting sphingosine kinase activation and subcellular localization may offer more specific therapeutic options than direct catalytic inhibition.
- Understanding SK/S1P regulation is key to developing treatments for cancer, inflammation, and other diseases.
- Further research into SKs' biological functions and therapeutic targeting is warranted.
More Related Videos
Related Concept Videos
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
01:12What are Second Messengers?
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
01:15Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:24Intracellular Signaling Cascades
Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
01:24Intracellular Signaling Cascades
Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...